by TractManager | Jul 28, 2023 | Emerging Technology Report
Exagamglogene autotemcel (Vertex Pharmaceuticals and CRISPR Therapeutics) is an investigational gene therapy delivered by autologous hematopoietic stem cell transplantation for the treatment of sickle cell disease.
by TractManager | Jul 28, 2023 | Emerging Technology Report
Lovotibeglogene autotemcel (Bluebird Bio Inc.) is an investigational gene therapy delivered by autologous hematopoietic stem cell transplantation for the treatment of sickle cell disease.
by TractManager | Jul 27, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ForeseeHome (Notal Vision Inc.) for the detection of choroidal neovascularization (CNV) associated with conversion...
by TractManager | Jul 25, 2023 | Emerging Technology Report
AspyreRx (Better Therapeutics Inc.) is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes (T2D). The device targets behavior to aid in the management of T2D in patients who...
by TractManager | Jul 25, 2023 | Emerging Technology Report
The automated low-flow ascites pump (alfapump; Sequana Medical NV) is an implantable wireless battery-powered pump for treatment of recurrent or refractory ascites due to liver cirrhosis.If you have a Hayes login, click here to view the full report on the Knowledge...
Recent Comments